Recovery
GLOW
Also called GHK-Cu + BPC-157 + TB-500
per administration
The amounts going around come from sellers and forums, not from any study.
Quick start
GLOW at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 1.5–3 mg per administration
- How often
- Every day
- Where
- Commonly subcutaneous Sites and rotation
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
What one draw delivers
| Component | Share | Per draw |
|---|---|---|
| GHK-Cu | 71% | 1.07 mg |
| BPC-157 | 14% | 214 mcg |
| TB-500 | 14% | 214 mcg |
Every draw has these same proportions.
1.5–3 mg of GLOW per administration, worked out from the components rather than quoted from a study of the blend.
A fixed-ratio blend of GHK-Cu, BPC-157 and TB-500 sold as one vial, so it is drawn as a whole. The range here is worked out from the components rather than quoted from a study of the blend: it is sized to keep GHK-Cu, which is about 71% of the vial, inside its own range, which also lands BPC-157 inside its range. TB-500 comes out below its standalone range at any draw that does so. Its components are covered on their own pages, and no combined human schedule is established, so no schedule table is shown.
What is in a 70 mg GLOW vial
| Component | Share | Per vial |
|---|---|---|
| GHK-Cu | 71% | 50 mg |
| BPC-157 | 14% | 10 mg |
| TB-500 | 14% | 10 mg |
Every draw has these same proportions.
Modelled level — every day
One curve per component: the components clear at very different rates.
Where these numbers come from
- Component literatureNo study exists of the blend itself; see the GHK-Cu, BPC-157 and TB-500 pages for the components' sources.